Compare RNST & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNST | LMAT |
|---|---|---|
| Founded | 1904 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 2.1B |
| IPO Year | 1997 | 2006 |
| Metric | RNST | LMAT |
|---|---|---|
| Price | $40.60 | $80.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $43.00 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 465.2K | 253.1K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.31% | 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | ★ 1.88 | 1.42 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | $31.72 | $14.21 |
| Revenue Next Year | $4.67 | $8.88 |
| P/E Ratio | ★ $21.79 | $56.51 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $33.04 | $78.27 |
| 52 Week High | $44.54 | $118.01 |
| Indicator | RNST | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.64 |
| Support Level | N/A | $78.77 |
| Resistance Level | N/A | $83.71 |
| Average True Range (ATR) | 0.00 | 1.83 |
| MACD | 0.00 | 0.60 |
| Stochastic Oscillator | 0.00 | 41.04 |
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.